Σύγκριση μεθόδων

	Ευθυγράμμιση Ακολουθιών με Βάση το Bayes	Ανάλυση Διαφορικής Έκφρασης RNA-seq
Πεδίο	Βιοπληροφορική	Βιοπληροφορική
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	2001–2005	2008–2010 (RNA-seq DE methodology established)
Δημιουργός	Ian Holmes & William J. Bruno; Benjamin Redelings & Marc Suchard	Multiple groups; foundational methods from Anders & Huber (DESeq, 2010), Robinson, McCarthy & Smyth (edgeR, 2010)
Τύπος	Probabilistic computational method	Quantitative genomics pipeline
Θεμελιώδης πηγή	Redelings, B. D., & Suchard, M. A. (2005). Joint Bayesian estimation of alignment and phylogeny. Systematic Biology, 54(3), 401–418.	Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550.
Εναλλακτικές ονομασίες	Bayesian MSA, probabilistic sequence alignment, statistical alignment, BAli-Phy alignment	RNA-seq DE analysis, transcriptomic differential expression, bulk RNA-seq DE, DEA
Συναφείς	5	6
Σύνοψη	Bayesian sequence alignment treats the alignment of biological sequences (DNA, RNA, or protein) as a probabilistic inference problem rather than a deterministic optimization. Instead of returning a single best alignment, it samples from a posterior distribution over all plausible alignments given a substitution model and gap penalty priors, thereby quantifying alignment uncertainty. It is particularly valuable when downstream analyses such as phylogenetic inference or functional annotation are sensitive to alignment error.	RNA-seq differential expression (DE) analysis identifies genes whose transcript abundance differs significantly between two or more biological conditions — for example, treated versus control, or diseased versus healthy tissue. Starting from raw sequencing reads, the pipeline moves through alignment, count-based normalization, statistical modeling of count dispersion, hypothesis testing, and multiple-testing correction to produce a ranked list of differentially expressed genes accompanied by fold-change estimates and adjusted p-values.